| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |